According to published results, a novel opioid-free pathway may provide noninferior pain management compared with an opioid-containing pathway during the perioperative period in patients undergoing ...
Dysmenorrhea Treatment Market size is expected to be worth around USD 10.1 Bn by 2032 from USD 4.7 Bn in 2023, growing at a CAGR of 8.2% ...
Patients who experience musculoskeletal pain have many pharmaceutical options for relief — unless they also suffer from ...
Fibromyalgia is a complex, chronic disorder characterized by widespread musculoskeletal pain, fatigue, sleep disturbances, ...